DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
Charity number: 1200037
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Unaudited
Trustees' Report and Financial Statements
For the Period Ended 31 March 2023
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group (A Charitable Incorporated Organisation)
Contents
| Page | |
|---|---|
| Reference and Administrative Details of the Charity, its Trustees and Advisers | 1 |
| Trustees' Report | 2 - 5 |
| Independent Examiner's Report | 6 - 7 |
| Statement of Financial Activities | 8 |
| Balance Sheet | 9 |
| Notes to the Financial Statements | 10 - 14 |
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Reference and Administrative Details of the Charity, its Trustees and Advisers For the Period Ended 31 March 2023
Trustees Robert Keith Lenthall, Chair Peter Anthony Flynn, Trustee Dr Anil Rajaram Gholkar, Trustee Dr Shawn Fergus Halpin, Trustee Hannah Mary Mulligan, Trustee Charity registered number 1200037 Principal office The Royal College of Radiologists 63 Lincoln's Inn Fields London WC2A 3JW Accountants ASM (B) Ltd 4th Floor Glendinning House 6 Murray Street Belfast Northern Ireland BT1 6DN
Page 1
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Trustees' Report For the Period Ended 31 March 2023
The Trustees present their annual report together with the financial statements of the UK Neurointerventional Group for the period 11 August 2022 to 31 March 2023. The Charity obtained registration with The Charity Commission for England and Wales on 11 August 2022. The Companies House number is CE029963.
Objectives and activities
a. Policies and objectives
The United Kingdom Neurointerventional Group (UKNG) represents Specialist Doctors who perform minimally invasive operations on the brain, spine, head and neck blood vessels. Their objective is to provide effective, safe and sustainable interventional neuroradiology.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public Benefit: running a charity (PB2)'.
The Charity has the following objectives, to:
-
Promote high standards in the clinical practice of Neurointervention throughout the UK;
-
Promote the place of Neurointervention (also known as Interventional Neuroradiology [INR]) as a core discipline of the clinical neurosciences;
-
Advise and collaborate with regulatory and professional bodies regarding development of guidelines and standards for the practice of interventional neuroradiology including diagnostic neuroradiology relevant to INR practice (which includes standards for facilities, delivery of service and professional abilities);
-
Support the clinical practice and continuing professional development of UK Neurointerventionists;
-
Ensure, in collaboration with the Royal College of Radiologists, the General Medical Council and any other relevant body, that training and education of Neurointerventionists & all those operating within this area of clinical practice are appropriate and of a high standard;
-
Monitor and advise on the number of UK INR trainees and training posts in order to assist in balancing supply and demand for Neurointerventionists;
-
Stimulate and encourage research and research networks including ethical collaboration with radiological and therapeutic equipment manufacturers and in particular to support the scientific evaluation of equipment and devices by high quality trials;
-
Develop and maintain relationships with national and international professional bodies relevant to Neurointervention;
-
Foster communication with patient groups; and
-
Promote Neurointervention to medical students, junior doctors and trainee radiologists as a rewarding and enjoyable career.
Page 2
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Trustees' Report (continued) For the Period Ended 31 March 2023
Objectives and activities (continued)
b. Strategies for achieving objectives
The Charity has the following strategies to achieve its objectives:
-
Publish standards, host and or promote scientific / educational meetings;
-
Interface with Royal College of Radiologists (RCR) and Allied Speciality Interest Groups (SIGs);
-
Work with the Royal College of Radiologists and regulatory bodies on clinical guidance, curriculum development, planning and delivery of training;
-
Run biannual UKNG meeting to provide forum for learning, sharing experience and encouraging good practice;
-
Respond to enquiries from, or concerns expressed by members;
-
Contribute to multidisciplinary work to develop clinical services;
-
Develop clinical guidance and cascade information to the INR community;
-
Network to break down barriers to research and foster good research practices;
-
Develop trainee days associated with UKNG meetings;
-
Encourage INR trainee involvement in UKNG work;
-
Cooperative work with patients groups / charities (Stroke Association); and
-
Develop a social media strategy.
c. Activities undertaken to achieve objectives
The Charity partakes in the following activities to achieve its objectives:
-
Run biannual UKNG meetings;
-
Work of the three UKNG sub-committees (Standards sub-committee, Training Education and Research subcommittee, Communications and Liaison sub-committee);
-
Encourage participation of UKNG members in the group’s activities;
-
Communication with allied Speciality Interest Groups: British Society of Neuroradiologists, British Society of Interventional Radiology, British Neurovascular Group Meeting, British & Irish Association of Stroke Physicians;
-
Run trainee educational days and webinars;
-
UKNG member contributions to the European Course in Minimally Invasive Neurological Therapy (and similar courses);
-
Run a UKNG / Industry liaison day;
-
Representation on the Intercollegiate Stroke Working Party;
-
Representation on the NHSE Thrombectomy Implementation Group;
-
Representation on various Royal College of Radiologists committees;
-
Publication of papers / commentaries covering standards, education, training and research;
-
Perform national surveys to gather data about INR and trainee numbers;
-
Coordinating research and audit activities;
-
Developing peer review processes; and
-
Engaging with marketing professionals to develop a social media profile and strategy.
d. Main activities undertaken to further the Charity's purposes for the public benefit
As well as likely public benefit from some of the activities listed above, the Charity undertakes the following activities for public benefit:
-
Work to expand availability of mechanical thrombectomy services in the UK;
-
Contribution to the Sentinel Stroke National Audit Programme; and
-
Contribution to Stroke Association activities including the Saving Brains campaign.
Page 3
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Trustees' Report (continued) For the Period Ended 31 March 2023
Achievements and performance
a. Main achievements of the Charity
The main achievements of the Charity were as follows:
-
Transition from informal Speciality Interest Group to a Charitable Incorporated Organisation;
-
Running UKNG meetings;
-
Representing the community of INRs in the UK;
-
Expanding INR / MT training opportunities in the UK;
-
Contributions to Royal College of Radiologists work (maintaining a focus on quality and standards); and
-
Engaging a marketing company.
Financial review
a. Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
b. Reserves policy
The Trustees ensure that the reserves remain at an adequate level to facilitate the hosting of their meetings, which occur twice a year. All reserves are unrestricted.
Structure, governance and management
a. Constitution
UK Neurointerventional Group is a registered charity, number 1200037, company number CE029963, and is constituted as a Charitable Incorporated Organisation.
b. Methods of appointment or election of Trustees
The management of the Charity is the responsibility of the Trustees who are elected and co-opted under the terms of the CIO - Foundation.
Page 4
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Trustees' Report (continued) For the Period Ended 31 March 2023
Statement of Trustees' responsibilities
The Trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England & Wales requires the Trustees to prepare financial statements for each financial period which give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgements and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the CIO. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees on 14 June 2024 and signed on their behalf by:
Peter Anthony Flynn (Trustee)
Page 5
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Independent Examiner's Report For the Period Ended 31 March 2023
Independent Examiner's Report to the Trustees of UK Neurointerventional Group ('the Charity')
I report to the charity Trustees on my examination of the accounts of the Charity for the period ended 31 March 2023.
Responsibilities and Basis of Report
As the Trustees of the Charity you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the 2011 Act').
I report in respect of my examination of the Charity's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent Examiner's Statement
Your attention is drawn to the fact that the Charity has prepared the accounts in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has been withdrawn.
I understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Charity as required by section 130 of the 2011 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination.
Page 6
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group (A Charitable Incorporated Organisation)
Independent Examiner's Report (continued) For the Period Ended 31 March 2023
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.
Signed:
Dated: 14 June 2024
Amanda McMaw FCA
ASM (B) Ltd
4th Floor Glendinning House 6 Murray Street Belfast Northern Ireland BT1 6DN
Page 7
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group (A Charitable Incorporated Organisation)
Statement of financial activities For the Period Ended 31 March 2023
| Note Income from: Charitable activities 2 Total income Expenditure on: Charitable activities 3 Total expenditure Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Unrestricted funds Period ended 31 March 2023 £ 26,749 26,749 31,317 31,317 (4,568) 102,883 (4,568) 98,315 |
Total funds Period ended 31 March 2023 £ 26,749 |
|---|---|---|
| 26,749 31,317 |
||
| 31,317 (4,568) 102,883 (4,568) |
||
| 98,315 |
The Statement of Financial Activities includes all gains and losses recognised in the period.
The notes on pages 10 to 14 form part of these financial statements.
Page 8
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Balance Sheet As at 31 March 2023
| Note Current assets Cash at bank and in hand Creditors: amounts falling due within one year 6 Net current assets Total assets less current liabilities Net assets Total net assets Charity funds Restricted funds 7 Unrestricted funds 7 Total funds |
100,315 100,315 (2,000) |
2023 £ 98,315 |
|---|---|---|
| 98,315 | ||
| 98,315 | ||
| 98,315 | ||
| - 98,315 |
||
| 98,315 |
The financial statements were approved and authorised for issue by the Trustees on 14 June 2024 and signed on their behalf by:
Peter Anthony Flynn
(Trustee)
The notes on pages 10 to 14 form part of these financial statements.
Page 9
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Notes to the Financial Statements For the Period Ended 31 March 2023
1. Accounting policies
1.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.
The financial statements have been prepared to give a 'true and fair' view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair' view. This departure has involved following the Charities SORP (FRS 102) published in October 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
UK Neurointerventional Group meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
1.2 Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
1.3 Income
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
1.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
1.5 Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
1.6 Cash at bank and in hand
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
Page 10
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Notes to the Financial Statements For the Period Ended 31 March 2023
1. Accounting policies (continued)
1.7 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.
1.8 Financial instruments
The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
1.9 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.
2. Income from charitable activities
| Subscriptions Sponsorship Bank interest |
Unrestricted funds Period ended 31 March 2023 £ 1,600 25,021 128 26,749 |
Total funds Period ended 31 March 2023 £ 1,600 25,021 128 |
|---|---|---|
| 26,749 |
Page 11
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Notes to the Financial Statements For the Period Ended 31 March 2023
3. Analysis of expenditure on charitable activities
Summary by fund type
| Conference fees Secretarial Professional General Travel |
Unrestricted funds Period ended 31 March 2023 £ 26,014 1,355 2,810 171 967 31,317 |
Total Period ended 31 March 2023 £ 26,014 1,355 2,810 171 967 |
|---|---|---|
| 31,317 |
4. Independent examiner's remuneration
| Period | |
|---|---|
| ended | |
| 31 March | |
| 2023 | |
| £ | |
| Fees payable to the Charity's independent examiner for the independent examination of | |
| the Charity's annual accounts | 2,000 |
Page 12
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group (A Charitable Incorporated Organisation)
Notes to the Financial Statements For the Period Ended 31 March 2023
5. Trustees' remuneration and expenses
During the period, no Trustees received any remuneration or other benefits.
During the period ended 31 March 2023, four Trustees incurred £967 of travel expenses which were reimbursed by the charity and disclosed at Note 3 of the Financial Statements.
6. Creditors: amounts falling due within one year
| 2023 | |
|---|---|
| £ | |
| Accruals and deferred income | 2,000 |
7. Statement of funds
Statement of funds - current period
| Balance at | Balance at | |||
|---|---|---|---|---|
| 11 August | 31 March | |||
| 2022 | Income | Expenditure | 2023 | |
| £ | £ | £ | £ | |
| Unrestricted funds | ||||
| General Funds - all funds | 102,883 | 26,749 | (31,317) | 98,315 |
UK Neurointerventional Group obtained charitable status on 11 August 2022 and the period ended 31 March 2023 is the first period for which Financial Statements have been prepared.
The opening fund as disclosed above relates to the bank balance of £102,883 as at 11 August 2022.
8. Summary of funds
Summary of funds - current period
| Balance at | Balance at | |||
|---|---|---|---|---|
| 11 August | 31 March | |||
| 2022 | Income | Expenditure | 2023 | |
| £ | £ | £ | £ | |
| General funds | 102,883 | 26,749 | (31,317) | 98,315 |
Page 13
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group
(A Charitable Incorporated Organisation)
Notes to the Financial Statements For the Period Ended 31 March 2023
9. Analysis of net assets between funds
Analysis of net assets between funds - current period
| Current assets Creditors due within one year Total |
Unrestricted funds 2023 £ 100,315 (2,000) 98,315 |
Total funds 2023 £ 100,315 (2,000) |
|---|---|---|
| 98,315 |
10. Related party transactions
There were no related party transactions during the period ended 31 March 2023.
Page 14
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
UK Neurointerventional Group The Royal College of Radiologists 63 Lincoln's Inn Fields London WC2A 3JW
Amanda McMaw FCA Independent Examiner ASM (B) Ltd 4[th] Floor Glendinning House 6 Murray Street Belfast BT1 6DN
14 June 2024
Dear Sirs
-
We provide this letter in connection with your examination of the financial statements of UK Neurointerventional Group for the period ended 31 March 2023.
-
We confirm, to the best of our knowledge and belief, that the following representations are made on the basis of enquiries of management and staff with relevant knowledge and experience and, where appropriate, of inspection of supporting documentation sufficient to satisfy ourselves that we can properly make each of the above representations to you.
-
We acknowledge our responsibility for the fair presentation of the financial statements in accordance with SORP (FRS 102).
-
We acknowledge as Trustees our responsibility for making accurate representations to you and for the financial statements of the CIO.
-
All accounting records and relevant information have been made available to you for the purpose of your examination.
-
All the transactions undertaken by the CIO have been properly reflected and recorded in the accounting records or other information provided to you. All other records and related information have been made available to you.
-
We confirm that the financial statements are free of material misstatements, including omissions.
-
No claims in connection with litigation have been or are expected to be received.
-
All grants, donations and other incoming resources, the receipt of which is subject to specific terms and conditions, have been notified to you. There have been no breaches of terms or conditions in the application of such incoming resources.
-
In the event that we publish the Trustee’s report, independent examiner’s report and financial statements electronically, we acknowledge our responsibility for ensuring that controls over the maintenance and integrity of the entity’s web site are adequate for this purpose.
-
There are no other liabilities or contingent liabilities other than those disclosed in the financial statements and we have disclosed in the financial statements all guarantees that we have given to third parties.
-
We confirm that no audit has been requested or is required.
DocuSign Envelope ID: E5F2AEA8-4B3B-40DF-BA42-643C6401EF6A
-
The CIO has satisfactory title to all assets and there are no liens or encumbrances on the CIO’s assets, except for those that are disclosed in the financial statements.
-
There have been no events since the balance sheet date which require disclosure or which would materially affect the amounts in the financial statements other than those already disclosed or included in the financial statements.
-
The CIO has at no time during the period made any arrangement, transaction or agreement to provide credit facilities (including loans, quasi loans or credit transactions) for the Trustee nor to guarantee or provide security for such matters.
-
We acknowledge our responsibility for the design and implementation of internal control to prevent and detect fraud and error.
-
We have disclosed to you the results of our assessment of the risk that the financial statements may be materially misstated as a result of fraud.
-
We have no knowledge of fraud or suspected fraud affecting the CIO involving management or those charged with governance.
-
We have disclosed to you our knowledge of any allegations of fraud, or suspected fraud, affecting the CIO’s financial statements communicated by employees, former employees, analysts, regulators or others.
-
We confirm that we are not aware of any possible or actual instance of noncompliance with those laws and regulations which provide a legal framework within which the CIO conducts its business.
-
The CIO has complied with all aspects of contractual agreements that could have a material effect on the financial statements in the event of non-compliance.
-
We confirm that complete information has been provided to you regarding the identification of related parties and that we are not aware of any significant transactions with related parties not previously disclosed.
-
We confirm that, having considered our future commitments and intentions for the next twelve months and the availability of reserves, the CIO is a going concern.
-
We have no plans or intentions that may materially alter the carrying value or classification of assets and liabilities reflected in the financial statements.
-
We confirm that UK Neurointerventional Group is a registered charity, and as such is entitled to certain tax exemptions on income and profits from investments, and surpluses on any trading activities carried on in furtherance of the CIO’s primary objectives, if these profits and surpluses are applied solely for charitable purposes.
-
We confirm that the accounts are made solely for the use of the Trustee and should not be used by any third parties without the prior consent of ASM (B) Ltd.
Yours faithfully,
Approved by the Trustee and signed on its behalf by
Peter Flynn, UK Neurointerventional Group 14 June 2024